期刊文献+

经导管动脉栓塞术中使用对比剂对肾功能的影响 被引量:4

Influence of contrast medium on renal function after transcatheter arterial embolization in bleeding patients caused by trauma
下载PDF
导出
摘要 目的探讨经导管动脉栓塞术(TAE)术中使用对比剂对外伤患者肾功能的影响。方法回顾性分析因腹部或盆腔急性外伤而接受TAE的80例患者,比较其术前及术后血清肌酐水平。结果术前血清肌酐为(1.02±0.24)mg/dl,术后为(0.94±0.26)mg/dl,略低于术前(P=0.01)。肾衰竭高危患者TAE后血清肌酐总体水平无明显增高。术后5例(5/80,6.25%)发生对比剂肾病,对比剂肾病发生率的95%可信区间为2%~11%;血清肌酐水平均于术后5天内恢复至基线水平。结论外伤患者TAE后可能发生对比剂肾病,但多为一过性的,TAE中使用对比剂是较为安全的。 Objective To explore the influence of contrast agent on renal function in bleeding patients caused by trauma and treated with transcatheter arterial embolization (TAE). Methods Eighty bleeding patients with abdominal or pelvic trauma underwent TAE were retrospectively analyzed, and whose serum creatinine level were observed pre-operatively and post-operatively. Results In 80 patients, the pre-operative serum creatinine was (l. 02±0. 24)mg/dl, and the post-opera- tive serum creatinine was (0.94±0.26)mg/dl, lower than the former (P=0.01). In patients with renal failure, the level of serum creatinine did not obviously increase. Contrast-induced nephropathy occurred in 5 cases (5/80, 6.25 %), the 95 % confidence interval of incidence rate was 2%-11%. The serum creatinine level went back to the baseline within 5 days. Conclusion Contrast-induced nephropathy may happen in traumatic bleeding patients after TAE, but it appears transiently for the majority patients, therefore the usage of contrast agent is safe.
出处 《中国介入影像与治疗学》 CSCD 2013年第4期222-225,共4页 Chinese Journal of Interventional Imaging and Therapy
关键词 对比剂 对比剂肾病 创伤和损伤 栓塞 治疗性 Contrast media Contrast nephropathy Wounds and injuries Embolization, therapeutic
  • 相关文献

参考文献16

  • 1Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after pereutaneous coronary intervention: Development and initial validation. J Am Coil Cardiol, 2004,44(7) : 1393-1399.
  • 2Glaser DS. Acute renal failure. N Engl J Med, 1996, 335(17) : 1321-1322.
  • 3Starr AJ. Arterial embolization is a rapid and effective technique for controlling pelvic fracture hemorrhage. J Trauma, 1998, 44 (1) :236.
  • 4Amini M, Salarifar M, Amirbaigloo A, et al. N-acetylcysteine does not prevent contrast-induced nephropathy after cardiac cathe- terization in patients with diabetes mellitus and chronic kidney dis- ease: A randomized clinical trial. Trials, 2009,10:45.
  • 5孙蔚明,杜晔.非离子型造影剂致肾损害的临床分析[J].中国医学影像学杂志,2005,13(4):284-287. 被引量:24
  • 6Bettmann MA. The evaluation oI contrast-related renal failure. AJR Am J Roentgenol, 1991,157(1) :66-68.
  • 7Aspelin P, Aubry P, Fransson SG et al. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med, 2003,348(6):491.
  • 8Liss P, Persson PB, Hansell P, et al. Renal failure in 57 925 pa- tients undergoing coronary procedures using iso-osmolar or low- osmolar contrast media. Kidney Int, 2006,70( 10):1811-1817.
  • 9Mehran R, Nikolsky E, Kirtane AJ, et al. Ionic low-osmolar ver- sus nonionic iso-osmolar contrast media to obviate worsening ne- phropathy after angioplasty in chronic renal failure patients: The ICON (lonic versus non-ionic Contrast to Obviate worsening Ne- phropathy after angioplasty in chronic renal failure patients) study. JACC Cardiovase Interv, 2009,2(5):415-421.
  • 10Hebert MF, Zheng S, Hays K, et al. Interpreting tacrolimus concentrations during pregnancy and postpartum. Transplanta- tion, 2012, 11(28) :1123 -1124.

二级参考文献56

  • 1刘璋,汤建荣,林成业,周飞,肖海松,李玉香,周运红,陆志峰,刘静.介入放射技术在肾损伤诊疗中的应用价值[J].中国介入影像与治疗学,2006,3(3):165-168. 被引量:23
  • 2Thomsen HS. Guidelines for contrast media from the europe, an society of urogenital, radiology [ J ]. Am J Roentgenol, 2003,181 (6) : 1463-1471.
  • 3Gupta R,Binbaum Y,Uretsky BF. The renal patient with coronary artery disease. Current concepts and dilemmas[ J]. J Am Coll Cardiol,2004,44 (7) : 1343-1353.
  • 4McCullough PA, Adam A, Becker CR,et al. Risk prediction of contrast-induced nephropathy [ J ]. Am J Cardiol, 2006,98 ( 6 ) : 27 -36.
  • 5Mueller C, Buerkle G, Buettner H, et al. Prevention of contrast media-associated nepbropathy [ J ]. Arch Intern Med, 2002, 162 ( 3 ) :329-336.
  • 6Merten GJ,Burgess WP, Gray LV,et al. Prevention of contrast-induced nephropathy with sodium bicarbonate[ J ]. J AMA ,2004,291 ( 19 ) :2328-2334.
  • 7Solomon RJ,Natarajan MK, Doucet S,et al. Cardiac angiographyin renally impaired patients ( CARE ) study. A randomized doubleblind trial of contrast-induced nephropatby in patients with chronic kidney disease [ J ]. Circulation ,2007,115 ( 25 ) : 3189 -3196.
  • 8Rudnick MR, Davidson C, Laskey W, et al. Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease:the Visipaque angiography/Interventions with Laboratory Outcomes in Renal Insufficiency(VALOR) Trial [ J]. Am Heart J, 2008, 156(4) :776-782.
  • 9Sharma SK. Iodinated contrast media and contrast-induced nephropathy:is there a preferred cost-effective agent? [J]. J Invasive Cardiol,2008,20 ( 5 ) : 245-248.
  • 10Nyman U, Bjork J,Aspelin P,et al. Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention[ J]. Acta Radiol,2008,49 (5) :658-667.

共引文献83

同被引文献24

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部